UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I

International journal of neonatal screening, 2023-02, Vol.9 (1), p.11

2023

Volltextzugriff (PDF)

First Three Years’ Experience of Mucopolysaccharidosis Type I Newborn Screening in California

The Journal of pediatrics, 2023-12, Vol.263, p.113644, Article 113644

2023

Volltextzugriff (PDF)

The Analysis of C26:0-Lysophosphatidylcholine for Detection of X-Linked Adrenoleukodystrophy Along With Amino Acids, Succinylacetone and Acylcarnitine in a Single Assay in the Genetic Disease Screening of Newborns

American journal of clinical pathology, 2015-10, Vol.144 (suppl_2), p.A063-A063

2015

Volltextzugriff (PDF)

Damaged goods?: an empirical cohort study of blood specimens collected 12 to 23 hours after birth in newborn screening in California

Genetics in medicine, 2016-03, Vol.18 (3), p.259-264

2016

Volltextzugriff (PDF)

California’s experience with SMA newborn screening: A successful path to early intervention

Journal of neuromuscular diseases, 2022-01, Vol.9 (6), p.777-785

2022

Volltextzugriff (PDF)

Improved tandem mass spectrometry (MS/MS) derivatized method for the detection of tyrosinemia type I, amino acids and acylcarnitine disorders using a single extraction process

Clinica chimica acta, 2011-05, Vol.412 (11-12), p.873-879

2011

Volltextzugriff (PDF)

Total Synthesis of Asimicin and Bullatacin

Journal of organic chemistry, 2000-09, Vol.65 (19), p.6035-6051

2000

Volltextzugriff (PDF)

In‐vitro metabolism studies with BLX‐1026, a novel Orexin‐2 agonist with anti‐obesity activity

The FASEB journal, 2008-03, Vol.22 (S1)

2008

Volltextzugriff (PDF)

Pharmacokinetic studies with BLX‐1026, a novel Orexin‐2 receptor agonist with anti‐obesity property, in rats

The FASEB journal, 2008-03, Vol.22 (S1)

2008

Volltextzugriff (PDF)

Anti‐inflammatory property of BLX‐1060, an orally active TNF‐α inhibitor

The FASEB journal, 2006-03, Vol.20 (4), p.A266-A266

2006

Volltextzugriff (PDF)

Synthesis and structure–Activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agents

Bioorganic & medicinal chemistry, 2003-09, Vol.11 (18), p.4059-4067

2003

Volltextzugriff (PDF)

BLX‐1060: A dose‐dependent efficacy study in collagen‐induced arthritis in mice

The FASEB journal, 2006-03, Vol.20 (5), p.A1127-A1127

2006

Volltextzugriff (PDF)

BLX‐1028, an orally active small molecules having anti‐adipogenic property, reduces weight gain, fat content and improves glucose tolerance in Diet Induced Obesity model in mice

The FASEB journal, 2006-03, Vol.20 (4), p.A266-A266

2006

Volltextzugriff (PDF)

Withaperuvins F and G, two withanolides of Physalis peruviana roots

Phytochemistry (Oxford), 1986-12, Vol.26 (1), p.243-247

1986

Volltextzugriff (PDF)

Withacoagin, a New Withanolide from Withania coagulans Roots

Bulletin of the Chemical Society of Japan, 1988-12, Vol.61 (12), p.4479-4481

1988

Volltextzugriff (PDF)

Total Synthesis of Mucocin

Journal of the American Chemical Society, 1998-11, Vol.120 (44), p.11279-11284

1998

Volltextzugriff (PDF)

A novel peroxisome proliferator-activated gamma (PPARγ) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential

Metabolism, clinical and experimental, 2003-08, Vol.52 (8), p.1012-1018

2003

Volltextzugriff (PDF)

OR 72: Amino acid conjugated small molecule BLX-1002 lowers blood glucose in insulin resistant db/db and ob/ob mice and inhibits TNF-[alpha] , IL-6 cytokines

American journal of hypertension, 2004-05, Vol.17 (S1), p.32A

2004

Volltextzugriff (PDF)

OR 72: Amino acid conjugated small molecule BLX-1002 lowers blood glucose in insulin resistant db/db and ob/ob mice and inhibits TNF-α , IL-6 cytokines

American journal of hypertension, 2004-05, Vol.17 (S1), p.32A-32A

2004

Volltextzugriff (PDF)

Amino acid conjugated small molecule BLX-1002 lowers blood glucose in insulin resistant db/db and ob/ob mice and inhibits TNF-α , IL-6 cytokines

American journal of hypertension, 2004, Vol.17 (5), p.S32-S32

2004

Volltextzugriff (PDF)

CLX-0940: A Non Thiazolidinedione PPAR Agonist and Insulin Sensitizer

Diabetes (New York, N.Y.), 2000-05, Vol.49 (5), p.A362

2000

Volltextzugriff (PDF)

Withaperuvin E and nicandrin B, withanolides from physalis peruviana and nicandra physaloides

Phytochemistry (Oxford), 1984-04, Vol.23 (4), p.853-855

1984

Volltextzugriff (PDF)

Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3beta-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPARgamma agonist activity

Journal of molecular endocrinology, 2004-04, Vol.32 (2), p.425-436

2004

Volltextzugriff (PDF)

CLX-0921: A New PPAR-[Gamma] Agonist Anti-Diabetic Thiazolidinedione Compound

Diabetes (New York, N.Y.), 2000-05, Vol.49 (5), p.A117

2000

Volltextzugriff (PDF)

A new anti-diabetic compound, CLX-0921: Efficacy in rodent models of type II diabetes and syndrome X

Diabetes research and clinical practice, 2000-09, Vol.50, p.344-344

2000

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(63)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Physical Sciences
(18)
Chemistry
(16)
Life Sciences & Biomedicine
(9)
Chemistry, Organic
(8)
Technology
(8)
Chemistry, Multidisciplinary
(6)
Humans
(6)
Engineering
(4)
Male
(4)
Materials Science
(4)
Materials Science, Multidisciplinary
(4)
Multi-Membered O
(4)
Newborn Screening
(4)
S-Heterocycles
(4)
Adsorption
(3)
Animals
(3)
Biological And Medical Sciences
(3)
Carbohydrates
(3)
Diabetes
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I

First Three Years’ Experience of Mucopolysaccharidosis Type I Newborn Screening in California

The Analysis of C26:0-Lysophosphatidylcholine for Detection of X-Linked Adrenoleukodystrophy Along With Amino Acids, Succinylacetone and Acylcarnitine in a Single Assay in the Genetic Disease Screening of Newborns

Damaged goods?: an empirical cohort study of blood specimens collected 12 to 23 hours after birth in newborn screening in California

California’s experience with SMA newborn screening: A successful path to early intervention

Improved tandem mass spectrometry (MS/MS) derivatized method for the detection of tyrosinemia type I, amino acids and acylcarnitine disorders using a single extraction process

Total Synthesis of Asimicin and Bullatacin

In‐vitro metabolism studies with BLX‐1026, a novel Orexin‐2 agonist with anti‐obesity activity

Pharmacokinetic studies with BLX‐1026, a novel Orexin‐2 receptor agonist with anti‐obesity property, in rats

Anti‐inflammatory property of BLX‐1060, an orally active TNF‐α inhibitor

Synthesis and structure–Activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agents

BLX‐1060: A dose‐dependent efficacy study in collagen‐induced arthritis in mice

BLX‐1028, an orally active small molecules having anti‐adipogenic property, reduces weight gain, fat content and improves glucose tolerance in Diet Induced Obesity model in mice

Withaperuvins F and G, two withanolides of Physalis peruviana roots

Withacoagin, a New Withanolide from Withania coagulans Roots

Total Synthesis of Mucocin

A novel peroxisome proliferator-activated gamma (PPARγ) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential

OR 72: Amino acid conjugated small molecule BLX-1002 lowers blood glucose in insulin resistant db/db and ob/ob mice and inhibits TNF-[alpha] , IL-6 cytokines

OR 72: Amino acid conjugated small molecule BLX-1002 lowers blood glucose in insulin resistant db/db and ob/ob mice and inhibits TNF-α , IL-6 cytokines

Amino acid conjugated small molecule BLX-1002 lowers blood glucose in insulin resistant db/db and ob/ob mice and inhibits TNF-α , IL-6 cytokines

CLX-0940: A Non Thiazolidinedione PPAR Agonist and Insulin Sensitizer

Withaperuvin E and nicandrin B, withanolides from physalis peruviana and nicandra physaloides

Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3beta-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPARgamma agonist activity

CLX-0921: A New PPAR-[Gamma] Agonist Anti-Diabetic Thiazolidinedione Compound

A new anti-diabetic compound, CLX-0921: Efficacy in rodent models of type II diabetes and syndrome X

Suchergebnisse filtern